Fundz

Intra-Cellular Therapies Appoints Sanjeev Narula as Executive Vice President, Chief Financial Officer

PRIVATEAug 08, 2024

Position

Chief Financial Officer

Company

Intra-Cellular Therapies

Sanjeev Narula
snarula@intracellulartherapies.com
New YorkBiotechnologyHealth CareTherapeuticsBiopharma

Description

Intra-Cellular Therapies, Inc. announced that Sanjeev Narula will join the Company on August 12, 2024 as Executive Vice President, Chief Financial Officer, reporting to Dr. Sharon Mates, ITCI’s Chairman and Chief Executive Officer.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Intra-Cellular Therapies, and when

A new leader at Intra-Cellular Therapies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Intra-Cellular Therapies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Intra-Cellular Therapies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Intra-Cellular Therapies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Intra-Cellular Therapies

Location

New York, New York, United States

About

Intra-Cellular Therapies is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The company leverages intracellular research to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Intra-Cellular Therapies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Michael
Likely contact at this company
••••••••@••••••••

See Michael's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Intra-Cellular Therapies's next move

Learn about Strategic plan

Intra-Cellular Therapies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.